ACAD
31.32
-0.39
-1.21%
AEMD
0.25
0.00
-1.19%
APRI
1.34
+0.12
+9.84%
ARNA
4.56
-0.21
-4.40%
ATEC
1.29
-0.03
-2.27%
CFN
59.54
-0.2
-0.33%
CNAT
5.79
-0.31
-5.05%
CRXM
0.21
+0.01
+6.01%
CYTX
0.48
-0.02
-3.37%
DXCM
60.57
-1.75
-2.81%
GNMK
13.06
-0.45
-3.33%
HALO
14.18
-0.3
-2.07%
ILMN
198.41
-4.84
-2.38%
INNV
0.2
+0.00
+0.05%
INO
8.5
-0.44
-4.92%
ISCO
0.06
0.00
-4.17%
ISIS
69.07
-3.33
-4.60%
LGND
57.32
-1.25
-2.13%
LPTN
2.89
-0.05
-1.70%
MBVX
1.15
+0.04
+3.60%
MEIP
3.69
0.00
0.00%
MNOV
3.74
+0.28
+8.09%
MRTX
20.34
-0.64
-3.05%
MSTX
0.45
0.00
-0.55%
NBIX
33.43
-0.11
-0.33%
NUVA
46.48
-0.45
-0.96%
ONCS
0.39
-0.01
-2.41%
ONVO
6.47
-0.12
-1.82%
OREX
5.49
-0.19
-3.26%
OTIC
31.54
-2.88
-8.37%
QDEL
24.3
-0.66
-2.64%
RCPT
113.22
-3.47
-2.97%
RGLS
17.47
-1.43
-7.57%
RMD
63.26
-1.94
-2.98%
SCIE
0.01
+0.00
+5.04%
SPHS
0.45
-0.04
-7.90%
SRNE
10.25
-0.37
-3.47%
TROV
5.82
-0.13
-2.12%
VICL
1.04
+0.01
+0.49%
VOLC
17.95
-0.02
-0.11%
ZGNX
1.35
-0.04
-2.75%
Home » Archive by Category

Syndication

aTyr Pharma Inc. Announces First FSHD Patient Study Of Resolaris

January 27, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 28, 2015 /PRNewswire/ — aTyr Pharma (“aTyr”), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address rare diseases, announced today its first FSHD patient clinical trial of Resol…

Adamis Pharmaceuticals Receives Notice Of Allowance For U.S. And Japanese Patents For Its Dry Powder Inhaler

January 27, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 28, 2015 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (Nasdaq:ADMP) (“Company…

MediciNova, Inc. Announces An Open Investigational New Drug (IND) Application For MN-001 In NASH

January 27, 2015 – 5:00 pm | Edit Post

LA JOLLA, Calif., Jan. 28, 2015 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that the IND (Inve…

Sorrento Therapeutics, Inc. Announces Completion Of Enrollment In The Cynviloq Registrational TRIBECA™ Study

January 27, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 28, 2015 /PRNewswire/ — Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), an oncology company developing new treatments for cancer and associated pain, announced today that the last patient in (total n 111 patients) has been rando…

Apricus Biosciences Announces Issuance Of U.S. Patent For Rayva

January 27, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 27, 2015 (GLOBE NEWSWIRE) — Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, announced that today, January 27, 2015, the United States Patent and Trademark…

Medtronic, Inc. Study Finds CoreValve System Benefits Aortic Stenosis Patients With Prior Coronary Bypass Surgery

January 27, 2015 – 5:00 pm | Edit Post

Analysis is First to Show Significant Advantages for Transcatheter Aortic Valve in Patients with Prior CABG DUBLIN and SAN DIEGO – January 28, 2015 – Medtronic plc (NYSE: MDT) revealed new one-year clinical data showing that transcatheter aortic valve …

Genalyte Inc. Completes First Phase Of National Cancer Institute Grant Program

January 27, 2015 – 5:00 pm | Edit Post

M.D. Anderson, Providence Cancer Center and Wayne State University Install New Technology and Testing Platform for Cancer ScreeningJanuary 28, 2015 (San Diego, CA) San Diego based biotechnology company Genalyte announced today the completion of Phase 1…

Illumina Reports Record Financial Results For Fourth Quarter And Fiscal Year 2014

January 27, 2015 – 5:00 pm | Edit Post

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the fourth quarter and fiscal year 2014. Fourth quarter 2014 results:• Revenue of $512 million, a 32% increase compared to $387 million in the four…

Illumina Reports Record Financial Results For Fourth Quarter And Fiscal Year 2014

January 27, 2015 – 5:00 pm | Edit Post

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the fourth quarter and fiscal year 2014. Fourth quarter 2014 results:• Revenue of $512 million, a 32% increase compared to $387 million in the four…

Ivera Medical Corporation Granted Renewal Of Its Minority-Owned Business Enterprise (MBE) Status

January 27, 2015 – 5:00 pm | Edit Post

SAN DIEGO, CA–(Marketwired – January 27, 2015) – Ivera Medical Corporation has met the stringent requirements for a minority-owned business enterprise (MBE) for the fourth consecutive year. The Pacific Southwest Minority Supplier Development Counc…